Tumay Bekci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tumay Bekci has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Serdar Aslan
Department of Radiology, Faculty of Medicine, Giresun University, Giresun, Turkiye
22 shared publications - Ismet Mirac Cakir
Samsun University, Faculty of Medicine, Department of Radiology, Samsun, Turkey. İ
12 shared publications - Gökhan Tonkaz
Department of Radiology, Faculty of Medicine, Giresun University, Giresun, Turkey
10 shared publications - Ramazan Orkun Onder
Department of Radiology, Faculty of Medicine, Giresun University, Giresun, Turkey.
10 shared publications - Uluhan Eryuruk
Giresun University
7 shared publications - Duygu Erkal
Department of Radiology, Faculty of Medicine, Giresun University, Giresun, Turkey
6 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by The European Research Journal in The European Research Journal
- p. 1-10
Comparison of the Diagnostic Performances of ACR-TIRADS, EU-TIRADS, and Bethesda Classifications in Predicting Malignancy in Thyroid Nodules
Objective: To compare the diagnostic performance of ultrasound-based risk stratification systems (ACR-TIRADS and EU-TIRADS) with the Bethesda classification in predicting thyroid nodule malignancy. Methods: This prospective cohort study included consecutive patients undergoing ultrasound-guided fine-needle aspiration biopsy between January 3 and December 30, 2024. Among 239 enrolled patients, 154 with histopathological confirmation following thyroidectomy were analyzed. Nodules were classified using ACR-TIRADS and EU-TIRADS criteria; cytological findings were categorized via the Bethesda system. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis, and independent predictors of malignancy were identified through logistic regression. Results: Among 154 operated patients, histopathology confirmed malignancy in 40.3% of nodules. Malignancy rates increased significantly with advancing categories across all 3 systems (P < .001). Individual performances were moderate and statistically similar: ACR-TIRADS (area under the curve [AUC], 0.72), EU-TIRADS (AUC, 0.71), and Bethesda (AUC, 0.72) (ACR-TIRADS vs EU-TIRADS, DeLong test, P = .70). Accuracy improved when all systems were combined (AUC, 0.78). On multivariable analysis, only Bethesda remained an independent predictor of malignancy (odds ratio, 1.96; P < .001). In the cytologically indeterminate Bethesda III–IV subgroup (n = 73), both TIRADS systems demonstrated high sensitivity (85.2%) but low specificity (37.0% to 39.1%; AUC range, 0.65 to 0.68). Conclusion: Bethesda cytology was the strongest independent predictor of thyroid malignancy. ACR-TIRADS and EU-TIRADS provide valuable complementary roles in determining biopsy indications, particularly for cytologically indeterminate nodules. Combined assessment optimizes diagnostic accuracy and supports clinical decision-making.
- 6 November 2026
- Published by The European Research Journal in The European Research Journal
- p. 1-10
Open AccessComparison of the Diagnostic Performances of ACR-TIRADS, EU-TIRADS, and Bethesda Classifications in Predicting Malignancy in Thyroid Nodules
Objective: To compare the diagnostic performance of ultrasound-based risk stratification systems (ACR-TIRADS and EU-TIRADS) with the Bethesda classification in predicting thyroid nodule malignancy. Methods: This prospective cohort study included consecutive patients undergoing ultrasound-guided fine-needle aspiration biopsy between January 3 and December 30, 2024. Among 239 enrolled patients, 154 with histopathological confirmation following thyroidectomy were analyzed. Nodules were classified using ACR-TIRADS and EU-TIRADS criteria; cytological findings were categorized via the Bethesda system. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis, and independent predictors of malignancy were identified through logistic regression. Results: Among 154 operated patients, histopathology confirmed malignancy in 40.3% of nodules. Malignancy rates increased significantly with advancing categories across all 3 systems (P < .001). Individual performances were moderate and statistically similar: ACR-TIRADS (area under the curve [AUC], 0.72), EU-TIRADS (AUC, 0.71), and Bethesda (AUC, 0.72) (ACR-TIRADS vs EU-TIRADS, DeLong test, P = .70). Accuracy improved when all systems were combined (AUC, 0.78). On multivariable analysis, only Bethesda remained an independent predictor of malignancy (odds ratio, 1.96; P < .001). In the cytologically indeterminate Bethesda III–IV subgroup (n = 73), both TIRADS systems demonstrated high sensitivity (85.2%) but low specificity (37.0% to 39.1%; AUC range, 0.65 to 0.68). Conclusion: Bethesda cytology was the strongest independent predictor of thyroid malignancy. ACR-TIRADS and EU-TIRADS provide valuable complementary roles in determining biopsy indications, particularly for cytologically indeterminate nodules. Combined assessment optimizes diagnostic accuracy and supports clinical decision-making.
- 12 August 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (11)
Development of the Medial Calcaneal Artery–to–Posterior Tibial Artery Diameter Ratio as a Predictor of Response after Superselective Embolization for Plantar Fasciitis: A Preliminary Derivation Study
- 12 August 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (11)
Development of the Medial Calcaneal Artery–to–Posterior Tibial Artery Diameter Ratio as a Predictor of Response after Superselective Embolization for Plantar Fasciitis: A Preliminary Derivation Study
- 25 November 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 195, 112573
Superselective embolization of the medial calcaneal artery: a minimally invasive and novel solution for rapid pain relief in plantar fasciitis
- 25 November 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 195, 112573
Superselective embolization of the medial calcaneal artery: a minimally invasive and novel solution for rapid pain relief in plantar fasciitis
- Open Access
- 3 November 2025
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 32 (3) , 328-337
Diagnostic performance of magnetic resonance imaging-targeted biopsy for PI-RADS ≥3 peripheral zone lesions in multiparametric prostate magnetic resonance imaging: correlation with clinically significant prostate cancer
To evaluate magnetic resonance imaging (MRI)-targeted biopsy (MRI-TB) performance in detecting clinically significant prostate cancer (csPCa) with a Prostate Imaging Reporting and Data System (PI-RADS) score of ≥3 peripheral zone (PZ) lesions using multiparametric MRI (mpMRI)-histopathology correlation. This retrospective study included 141 patients with 187 PZ lesions who underwent mpMRI followed by both MRI-TB and transrectal ultrasound-guided systematic biopsy (SB) between December 2021 and December 2024. All mpMRI scans were evaluated by a board-certified experienced radiologist in accordance with the PI-RADS version 2.1 criteria. The csPCa detection rates of SB, MRI-TB, and combined biopsy (CB) were compared. Statistical analyses included McNemar's test, Fisher's exact test, and the Mann-Whitney U test. A P value P = 0.02), lower prostate volume (52.4 vs. 78.6 mL; P < 0.001), and three-fold higher PSA density (PSAD) (0.30 vs. 0.10 ng/mL/mL; P < 0.001) than non-csPCa cases. Notably, PSAD > 0.15 ng/mL/mL occurred in 78% of patients with csPCa vs. 18% in non-csPCa cases (P < 0.001). Moreover, MRI-TB detected significantly more csPCa than SB (17.7% vs. 10.7% of lesions; P < 0.001), with maximal advantage in PI-RADS 4 lesions (20.7% vs. 10.9%; P = 0.004). By contrast, CB did not significantly increase csPCa detection over MRI-TB alone (19.8% vs. 17.7%; P = 0.125). Chronic prostatitis (CP) (34.0% of benign cases) confounded PI-RADS specificity. For csPCa detection in PI-RADS ≥3 PZ lesions, particularly PI-RADS 4, MRI-TB outperforms SB. For PI-RADS 5, SB and MRI-TB showed equivalent efficacy. However, MRI-TB alone suffices for PI-RADS ≥4 lesions or PSAD >0.15 ng/mL/mL, whereas CB remains preferable for PI-RADS 3. The high CP prevalence underscores the need for adjunctive biomarkers to improve specificity. MRI-TB optimizes csPCa detection for PI-RADS ≥4 PZ lesions, reducing reliance on SBs. A PSAD threshold >0.15 ng/mL/mL effectively stratifies biopsy necessity, and high CP prevalence (34% of benign cases) underscores the need for adjunct biomarkers to improve specificity in PI-RADS 3-4 lesions.
- 3 November 2025
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 32 (3) , 328-337
Open AccessDiagnostic performance of magnetic resonance imaging-targeted biopsy for PI-RADS ≥3 peripheral zone lesions in multiparametric prostate magnetic resonance imaging: correlation with clinically significant prostate cancer
To evaluate magnetic resonance imaging (MRI)-targeted biopsy (MRI-TB) performance in detecting clinically significant prostate cancer (csPCa) with a Prostate Imaging Reporting and Data System (PI-RADS) score of ≥3 peripheral zone (PZ) lesions using multiparametric MRI (mpMRI)-histopathology correlation. This retrospective study included 141 patients with 187 PZ lesions who underwent mpMRI followed by both MRI-TB and transrectal ultrasound-guided systematic biopsy (SB) between December 2021 and December 2024. All mpMRI scans were evaluated by a board-certified experienced radiologist in accordance with the PI-RADS version 2.1 criteria. The csPCa detection rates of SB, MRI-TB, and combined biopsy (CB) were compared. Statistical analyses included McNemar's test, Fisher's exact test, and the Mann-Whitney U test. A P value P = 0.02), lower prostate volume (52.4 vs. 78.6 mL; P < 0.001), and three-fold higher PSA density (PSAD) (0.30 vs. 0.10 ng/mL/mL; P < 0.001) than non-csPCa cases. Notably, PSAD > 0.15 ng/mL/mL occurred in 78% of patients with csPCa vs. 18% in non-csPCa cases (P < 0.001). Moreover, MRI-TB detected significantly more csPCa than SB (17.7% vs. 10.7% of lesions; P < 0.001), with maximal advantage in PI-RADS 4 lesions (20.7% vs. 10.9%; P = 0.004). By contrast, CB did not significantly increase csPCa detection over MRI-TB alone (19.8% vs. 17.7%; P = 0.125). Chronic prostatitis (CP) (34.0% of benign cases) confounded PI-RADS specificity. For csPCa detection in PI-RADS ≥3 PZ lesions, particularly PI-RADS 4, MRI-TB outperforms SB. For PI-RADS 5, SB and MRI-TB showed equivalent efficacy. However, MRI-TB alone suffices for PI-RADS ≥4 lesions or PSAD >0.15 ng/mL/mL, whereas CB remains preferable for PI-RADS 3. The high CP prevalence underscores the need for adjunctive biomarkers to improve specificity. MRI-TB optimizes csPCa detection for PI-RADS ≥4 PZ lesions, reducing reliance on SBs. A PSAD threshold >0.15 ng/mL/mL effectively stratifies biopsy necessity, and high CP prevalence (34% of benign cases) underscores the need for adjunct biomarkers to improve specificity in PI-RADS 3-4 lesions.
- 25 October 2025
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 47 (1) , 17-25
Comparative Evaluation of BI-RADS Classification, Clinical Management, and Diagnostic Performance in Breast Ultrasound Reports Using ChatGPT-4o and DeepSeek-V3
- 25 October 2025
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 47 (1) , 17-25
Comparative Evaluation of BI-RADS Classification, Clinical Management, and Diagnostic Performance in Breast Ultrasound Reports Using ChatGPT-4o and DeepSeek-V3
- Open Access
- 30 June 2025
- Published by Giresun Training and Research Hospital in Cerasus Journal of Medicine
- Vol. 2 (2) , 100-108
Diagnostic Accuracy of Ultrasonography-Guided Percutaneous Core Needle Biopsies of Pancreatic Lesions
Objective This study evaluates the results and complications of ultrasound-guided percutaneous core needle biopsies for solid masses of the pancreas performed at our university hospital . Methods Between January 2009 and June 2013 A total of 60 biopsy procedures were performed in 53 patients (30 males, 23 females) and 11 specimens were benign and 45 specimens were malignant according to histopathologic results. Results Sensitivity was 84.9%, specificity was 100% and diagnostic accuracy was 85.7%. No complications were observed during or after biopsy procedures Conclusion This study shows that ultrasound-guided biopsy is a reliable, time- and cost-saving method with a very low complication rate, high diagnostic accuracy and sensitivity, but benign biopsy findings should not be used to exclude the presence of pancreatic malignancy and biopsy should be repeated if there is a high clinical suspicion of malignancy.
- 30 June 2025
- Published by Giresun Training and Research Hospital in Cerasus Journal of Medicine
- Vol. 2 (2) , 100-108
Open AccessDiagnostic Accuracy of Ultrasonography-Guided Percutaneous Core Needle Biopsies of Pancreatic Lesions
Objective This study evaluates the results and complications of ultrasound-guided percutaneous core needle biopsies for solid masses of the pancreas performed at our university hospital . Methods Between January 2009 and June 2013 A total of 60 biopsy procedures were performed in 53 patients (30 males, 23 females) and 11 specimens were benign and 45 specimens were malignant according to histopathologic results. Results Sensitivity was 84.9%, specificity was 100% and diagnostic accuracy was 85.7%. No complications were observed during or after biopsy procedures Conclusion This study shows that ultrasound-guided biopsy is a reliable, time- and cost-saving method with a very low complication rate, high diagnostic accuracy and sensitivity, but benign biopsy findings should not be used to exclude the presence of pancreatic malignancy and biopsy should be repeated if there is a high clinical suspicion of malignancy.
- 16 May 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 189, 112174
Improving the diagnostic accuracy of small renal masses: Integration of radiomics and clear cell likelihood scores in multiparametric MRI
- 16 May 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 189, 112174
Improving the diagnostic accuracy of small renal masses: Integration of radiomics and clear cell likelihood scores in multiparametric MRI